JNJ vs ELV
By Alex · Tickerpine
Johnson & Johnson vs Elevance Health, Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | ELV |
|---|---|---|
| Price | $271.22 | $396.09 |
| Market cap | $653.61B | $85.90B |
| P/E ratio | 31.5 | 17.5 |
| ROE | 25.74% | 11.13% |
| Profit margin | 21.48% | 2.47% |
| Revenue growth | 6.60% | 1.40% |
| Dividend yield | 1.98% | 1.74% |
| Beta | 0.23 | 0.70 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs ELV in plain English
- JNJ is the bigger company — about 7.6× the market cap of ELV.
- ELV is cheaper on earnings (P/E 17.5 vs 31.5).
- JNJ earns a higher return on equity (26% vs 11%).
- JNJ is growing revenue faster (7% vs 1%).
- JNJ has the higher dividend yield (1.98% vs 1.74%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
ELV return calculator
See what $1,000 in Elevance Health, Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.